| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 27 | 2025 | 979 | 4.080 |
Why?
|
| Apoptosis | 35 | 2025 | 1541 | 3.710 |
Why?
|
| Lymphoma | 7 | 2023 | 38 | 3.040 |
Why?
|
| Piperidones | 5 | 2022 | 9 | 2.350 |
Why?
|
| Pyrazoles | 4 | 2025 | 93 | 1.820 |
Why?
|
| Cell Line, Tumor | 34 | 2025 | 2598 | 1.660 |
Why?
|
| Endodeoxyribonucleases | 6 | 2017 | 29 | 1.630 |
Why?
|
| Leukemia | 6 | 2021 | 54 | 1.620 |
Why?
|
| Tubulin | 2 | 2024 | 94 | 1.020 |
Why?
|
| Pyridazines | 2 | 2025 | 16 | 0.830 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 40 | 0.830 |
Why?
|
| Drug Screening Assays, Antitumor | 11 | 2023 | 147 | 0.820 |
Why?
|
| Awards and Prizes | 1 | 2022 | 28 | 0.770 |
Why?
|
| DNA | 9 | 2011 | 594 | 0.750 |
Why?
|
| Signal Transduction | 9 | 2025 | 2111 | 0.720 |
Why?
|
| Humans | 60 | 2025 | 42163 | 0.700 |
Why?
|
| Thiazolidinediones | 4 | 2021 | 49 | 0.650 |
Why?
|
| DNA Fragmentation | 7 | 2021 | 95 | 0.640 |
Why?
|
| Minority Groups | 3 | 2022 | 663 | 0.630 |
Why?
|
| Deoxyribonucleases | 2 | 2014 | 27 | 0.630 |
Why?
|
| Membrane Potential, Mitochondrial | 6 | 2025 | 89 | 0.620 |
Why?
|
| DNA-Binding Proteins | 7 | 2002 | 557 | 0.620 |
Why?
|
| Reactive Oxygen Species | 7 | 2025 | 518 | 0.610 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 189 | 0.610 |
Why?
|
| Naphthyridines | 1 | 2018 | 5 | 0.600 |
Why?
|
| Structure-Activity Relationship | 13 | 2025 | 491 | 0.600 |
Why?
|
| Cell Proliferation | 10 | 2025 | 1420 | 0.580 |
Why?
|
| Caspase 3 | 6 | 2025 | 226 | 0.570 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 115 | 0.550 |
Why?
|
| Burkholderia | 1 | 2017 | 17 | 0.530 |
Why?
|
| Neoplasms | 4 | 2023 | 1341 | 0.500 |
Why?
|
| Animals | 34 | 2025 | 16695 | 0.470 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 1679 | 0.460 |
Why?
|
| Mice | 21 | 2025 | 6490 | 0.450 |
Why?
|
| Amino Acid Sequence | 9 | 2017 | 1188 | 0.440 |
Why?
|
| Curcumin | 1 | 2016 | 115 | 0.440 |
Why?
|
| Quantum Dots | 2 | 2025 | 38 | 0.430 |
Why?
|
| Ketoconazole | 1 | 2013 | 8 | 0.420 |
Why?
|
| Clotrimazole | 1 | 2013 | 4 | 0.420 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 1559 | 0.420 |
Why?
|
| Ruthenium | 1 | 2013 | 16 | 0.420 |
Why?
|
| Phosphatidylserines | 4 | 2022 | 21 | 0.410 |
Why?
|
| Enzyme Activation | 3 | 2022 | 462 | 0.410 |
Why?
|
| Cell Cycle | 5 | 2025 | 348 | 0.400 |
Why?
|
| Cell Survival | 11 | 2020 | 934 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2022 | 152 | 0.390 |
Why?
|
| Stress, Physiological | 1 | 2014 | 170 | 0.390 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 580 | 0.380 |
Why?
|
| Science | 1 | 2012 | 23 | 0.370 |
Why?
|
| Career Choice | 1 | 2012 | 51 | 0.370 |
Why?
|
| Homeodomain Proteins | 3 | 1998 | 144 | 0.360 |
Why?
|
| Melanoma | 2 | 2023 | 109 | 0.360 |
Why?
|
| Evolution, Molecular | 2 | 2017 | 299 | 0.360 |
Why?
|
| Organotin Compounds | 1 | 2010 | 2 | 0.340 |
Why?
|
| Mentors | 1 | 2012 | 143 | 0.340 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2020 | 122 | 0.340 |
Why?
|
| Sequence Alignment | 4 | 2017 | 273 | 0.340 |
Why?
|
| Cultural Diversity | 1 | 2012 | 187 | 0.330 |
Why?
|
| Ruthenium Compounds | 1 | 2010 | 1 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 933 | 0.330 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2017 | 271 | 0.330 |
Why?
|
| Lactoferrin | 2 | 2020 | 8 | 0.330 |
Why?
|
| Caspases | 2 | 2022 | 148 | 0.320 |
Why?
|
| Phylogeny | 2 | 2017 | 740 | 0.310 |
Why?
|
| Molecular Structure | 7 | 2023 | 560 | 0.310 |
Why?
|
| Drug Design | 2 | 2021 | 183 | 0.300 |
Why?
|
| Carbon | 3 | 2025 | 127 | 0.300 |
Why?
|
| Ubiquitinated Proteins | 2 | 2019 | 6 | 0.300 |
Why?
|
| Propranolol | 2 | 2019 | 17 | 0.290 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 228 | 0.290 |
Why?
|
| Autoantibodies | 2 | 2022 | 112 | 0.280 |
Why?
|
| Repressor Proteins | 2 | 2021 | 267 | 0.280 |
Why?
|
| Biological Assay | 2 | 2005 | 63 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2002 | 534 | 0.280 |
Why?
|
| Hydroquinones | 2 | 2020 | 10 | 0.270 |
Why?
|
| Endonucleases | 3 | 1997 | 18 | 0.270 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2018 | 98 | 0.270 |
Why?
|
| Muramidase | 2 | 2025 | 31 | 0.270 |
Why?
|
| Nuclear Proteins | 5 | 2015 | 330 | 0.270 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 254 | 0.270 |
Why?
|
| Lysosomes | 1 | 2007 | 88 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 1066 | 0.260 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2022 | 158 | 0.260 |
Why?
|
| Flow Cytometry | 3 | 2016 | 411 | 0.260 |
Why?
|
| Recombination, Genetic | 5 | 1997 | 96 | 0.260 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 211 | 0.250 |
Why?
|
| Hordeum | 2 | 2019 | 15 | 0.250 |
Why?
|
| Base Sequence | 11 | 2002 | 997 | 0.250 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 683 | 0.250 |
Why?
|
| Glucose Transporter Type 1 | 3 | 2020 | 19 | 0.250 |
Why?
|
| Temperature | 3 | 2019 | 314 | 0.250 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 207 | 0.250 |
Why?
|
| Hela Cells | 7 | 2021 | 370 | 0.240 |
Why?
|
| Arthritis, Experimental | 1 | 2025 | 8 | 0.240 |
Why?
|
| Phosphorylation | 4 | 2022 | 973 | 0.240 |
Why?
|
| DNA Damage | 1 | 2007 | 358 | 0.230 |
Why?
|
| Neuropeptide Y | 1 | 2025 | 26 | 0.230 |
Why?
|
| Necrosis | 2 | 2019 | 54 | 0.230 |
Why?
|
| Immunity, Innate | 1 | 2006 | 168 | 0.230 |
Why?
|
| Female | 12 | 2024 | 24018 | 0.230 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 1068 | 0.230 |
Why?
|
| Sirolimus | 1 | 2025 | 70 | 0.230 |
Why?
|
| Quinones | 1 | 2004 | 17 | 0.230 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2025 | 53 | 0.230 |
Why?
|
| Toxicity Tests | 1 | 2004 | 45 | 0.220 |
Why?
|
| Tubulin Modulators | 1 | 2024 | 18 | 0.220 |
Why?
|
| Agriculture | 1 | 2005 | 65 | 0.220 |
Why?
|
| Amyloid | 1 | 2025 | 66 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2020 | 1112 | 0.220 |
Why?
|
| Binding Sites | 6 | 2021 | 670 | 0.220 |
Why?
|
| Pyrimidines | 1 | 2025 | 130 | 0.210 |
Why?
|
| Nitrogen | 1 | 2025 | 83 | 0.210 |
Why?
|
| Histone Deacetylases | 2 | 2021 | 61 | 0.210 |
Why?
|
| Thiophenes | 1 | 2023 | 30 | 0.210 |
Why?
|
| Bacteria | 2 | 2011 | 285 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2022 | 78 | 0.200 |
Why?
|
| Eukaryotic Cells | 2 | 2017 | 36 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2022 | 467 | 0.200 |
Why?
|
| Graphite | 1 | 2024 | 61 | 0.200 |
Why?
|
| Cloning, Molecular | 5 | 2014 | 318 | 0.200 |
Why?
|
| Enzyme Inhibitors | 1 | 2025 | 457 | 0.200 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2025 | 183 | 0.190 |
Why?
|
| Antibodies, Neoplasm | 1 | 2022 | 20 | 0.190 |
Why?
|
| Cell Death | 2 | 2022 | 277 | 0.190 |
Why?
|
| Surface-Active Agents | 2 | 2013 | 44 | 0.190 |
Why?
|
| Ionic Liquids | 1 | 2022 | 20 | 0.190 |
Why?
|
| Models, Molecular | 5 | 2020 | 875 | 0.190 |
Why?
|
| Sp1 Transcription Factor | 1 | 2002 | 49 | 0.190 |
Why?
|
| Drosophila | 2 | 2002 | 150 | 0.190 |
Why?
|
| Oximes | 1 | 2021 | 6 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 77 | 0.180 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2021 | 33 | 0.180 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Exocytosis | 1 | 2022 | 49 | 0.180 |
Why?
|
| Copper | 2 | 2017 | 134 | 0.180 |
Why?
|
| Biocompatible Materials | 3 | 2025 | 106 | 0.180 |
Why?
|
| Heme Oxygenase-1 | 1 | 2021 | 52 | 0.180 |
Why?
|
| Risk-Taking | 1 | 2005 | 456 | 0.180 |
Why?
|
| Thiadiazoles | 1 | 2021 | 6 | 0.170 |
Why?
|
| Cell Line | 8 | 2020 | 1416 | 0.170 |
Why?
|
| Prostate | 1 | 2022 | 152 | 0.170 |
Why?
|
| PPAR gamma | 1 | 2021 | 55 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2019 | 990 | 0.170 |
Why?
|
| Microtubules | 1 | 2022 | 120 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 284 | 0.170 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2020 | 13 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2019 | 54 | 0.170 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2020 | 31 | 0.170 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 14 | 0.170 |
Why?
|
| Mutation | 4 | 2020 | 1169 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2018 | 534 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 175 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 56 | 0.160 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 19 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 729 | 0.160 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 44 | 0.160 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 78 | 0.160 |
Why?
|
| Sulfonamides | 1 | 2020 | 88 | 0.160 |
Why?
|
| Needles | 1 | 2019 | 11 | 0.160 |
Why?
|
| Protein Conformation | 2 | 2017 | 420 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2019 | 23 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.150 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 385 | 0.150 |
Why?
|
| Organometallic Compounds | 2 | 2011 | 72 | 0.150 |
Why?
|
| B-Lymphocytes | 3 | 1996 | 183 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 2019 | 50 | 0.150 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2019 | 76 | 0.150 |
Why?
|
| Crystallography, X-Ray | 2 | 2017 | 285 | 0.150 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 8 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 49 | 0.150 |
Why?
|
| Polyubiquitin | 1 | 2018 | 7 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 21 | 0.150 |
Why?
|
| Mitochondria | 2 | 2020 | 516 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2019 | 124 | 0.140 |
Why?
|
| Molecular Weight | 1 | 2018 | 168 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 180 | 0.140 |
Why?
|
| Biological Transport | 1 | 2018 | 201 | 0.140 |
Why?
|
| Spleen | 2 | 1997 | 199 | 0.140 |
Why?
|
| Plant Extracts | 2 | 2019 | 303 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 479 | 0.140 |
Why?
|
| Cell Movement | 1 | 2022 | 640 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 1998 | 158 | 0.140 |
Why?
|
| Prokaryotic Cells | 1 | 2017 | 9 | 0.140 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2017 | 24 | 0.130 |
Why?
|
| Genes, Switch | 1 | 1997 | 3 | 0.130 |
Why?
|
| Proteins | 2 | 1997 | 383 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 297 | 0.130 |
Why?
|
| Catalytic Domain | 1 | 2017 | 118 | 0.130 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 522 | 0.130 |
Why?
|
| Students | 1 | 2022 | 617 | 0.130 |
Why?
|
| Protein Folding | 1 | 2017 | 123 | 0.130 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 207 | 0.130 |
Why?
|
| Imidazoles | 2 | 2021 | 138 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 293 | 0.120 |
Why?
|
| Immunoglobulin Switch Region | 1 | 1996 | 3 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 36 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2019 | 324 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2013 | 1617 | 0.120 |
Why?
|
| Male | 7 | 2025 | 22779 | 0.120 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 92 | 0.120 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 1995 | 2 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2002 | 722 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1058 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 47 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2014 | 37 | 0.110 |
Why?
|
| Cations | 1 | 2014 | 49 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 136 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 205 | 0.110 |
Why?
|
| Piperidines | 1 | 2014 | 80 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 72 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 1995 | 201 | 0.100 |
Why?
|
| Xylose | 1 | 2013 | 12 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 295 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 508 | 0.100 |
Why?
|
| Surface Properties | 3 | 2024 | 157 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2006 | 461 | 0.100 |
Why?
|
| Triazoles | 1 | 2013 | 100 | 0.100 |
Why?
|
| Cerium | 1 | 2012 | 18 | 0.090 |
Why?
|
| Alginates | 1 | 2012 | 19 | 0.090 |
Why?
|
| Research Support as Topic | 1 | 2012 | 89 | 0.090 |
Why?
|
| Phosphines | 1 | 2011 | 7 | 0.090 |
Why?
|
| Glycosides | 1 | 2011 | 22 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 134 | 0.090 |
Why?
|
| Benzylidene Compounds | 1 | 2011 | 5 | 0.090 |
Why?
|
| Cytotoxins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Platinum | 1 | 2011 | 23 | 0.090 |
Why?
|
| Alkenes | 1 | 2011 | 16 | 0.090 |
Why?
|
| Palladium | 1 | 2011 | 30 | 0.090 |
Why?
|
| Coordination Complexes | 1 | 2011 | 28 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2011 | 93 | 0.090 |
Why?
|
| Gene Expression | 1 | 2014 | 692 | 0.090 |
Why?
|
| Titanium | 1 | 2011 | 46 | 0.090 |
Why?
|
| Intercalating Agents | 1 | 2010 | 13 | 0.090 |
Why?
|
| Annexin A5 | 1 | 2010 | 27 | 0.090 |
Why?
|
| Propidium | 1 | 2010 | 20 | 0.090 |
Why?
|
| Sulfides | 1 | 2011 | 77 | 0.090 |
Why?
|
| Amides | 1 | 2011 | 72 | 0.090 |
Why?
|
| Soil Pollutants | 1 | 2012 | 104 | 0.080 |
Why?
|
| Fungi | 2 | 2011 | 103 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 74 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 428 | 0.080 |
Why?
|
| Zea mays | 1 | 2012 | 74 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2021 | 158 | 0.080 |
Why?
|
| HIV Infections | 1 | 2005 | 2535 | 0.080 |
Why?
|
| Chloroquine | 1 | 2010 | 19 | 0.080 |
Why?
|
| Host-Parasite Interactions | 1 | 2010 | 75 | 0.080 |
Why?
|
| Organogold Compounds | 1 | 2009 | 3 | 0.080 |
Why?
|
| Plasmids | 2 | 2007 | 247 | 0.080 |
Why?
|
| Immunoglobulins | 2 | 1986 | 39 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 170 | 0.080 |
Why?
|
| Trypanosoma cruzi | 1 | 2010 | 154 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1987 | 22 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 227 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2010 | 278 | 0.070 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1987 | 4 | 0.070 |
Why?
|
| Amoeba | 1 | 2007 | 6 | 0.070 |
Why?
|
| Eukaryota | 1 | 2007 | 20 | 0.070 |
Why?
|
| Micrococcus luteus | 1 | 2006 | 4 | 0.060 |
Why?
|
| Hemocytes | 1 | 2006 | 11 | 0.060 |
Why?
|
| Plants | 1 | 2007 | 114 | 0.060 |
Why?
|
| Liposomes | 1 | 2007 | 130 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2006 | 44 | 0.060 |
Why?
|
| Plasmacytoma | 1 | 1985 | 11 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 1985 | 27 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 1997 | 217 | 0.060 |
Why?
|
| Mycobacterium avium | 1 | 2005 | 4 | 0.060 |
Why?
|
| Fluorometry | 1 | 2005 | 17 | 0.060 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 1996 | 4 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1985 | 63 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 1985 | 53 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 59 | 0.060 |
Why?
|
| Middle Aged | 4 | 2020 | 11819 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2025 | 72 | 0.060 |
Why?
|
| RNA Interference | 1 | 2006 | 246 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1574 | 0.060 |
Why?
|
| Acetophenones | 1 | 2005 | 10 | 0.060 |
Why?
|
| Naphthoquinones | 1 | 2005 | 41 | 0.060 |
Why?
|
| Mycobacterium | 1 | 2005 | 16 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2006 | 1265 | 0.060 |
Why?
|
| Transients and Migrants | 1 | 2005 | 42 | 0.060 |
Why?
|
| Safe Sex | 1 | 2005 | 78 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2005 | 205 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2005 | 168 | 0.050 |
Why?
|
| Autophagy | 1 | 2025 | 136 | 0.050 |
Why?
|
| Data Collection | 1 | 2005 | 210 | 0.050 |
Why?
|
| Transfection | 3 | 2007 | 526 | 0.050 |
Why?
|
| Mexico | 1 | 2005 | 286 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1586 | 0.050 |
Why?
|
| Phototherapy | 1 | 2023 | 25 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2023 | 82 | 0.050 |
Why?
|
| Particle Size | 1 | 2024 | 267 | 0.050 |
Why?
|
| Cattle | 2 | 2011 | 505 | 0.050 |
Why?
|
| Texas | 1 | 2005 | 428 | 0.050 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2002 | 2 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 138 | 0.050 |
Why?
|
| Genes, Insect | 1 | 2002 | 27 | 0.050 |
Why?
|
| Light | 1 | 2023 | 182 | 0.050 |
Why?
|
| Sp3 Transcription Factor | 1 | 2002 | 8 | 0.050 |
Why?
|
| Caprylates | 1 | 2022 | 10 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2022 | 48 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 106 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 96 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 198 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2002 | 88 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2020 | 2485 | 0.050 |
Why?
|
| Choline | 1 | 2022 | 61 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 189 | 0.050 |
Why?
|
| Proteome | 1 | 2022 | 150 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 191 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 98 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 415 | 0.040 |
Why?
|
| Benzyl Compounds | 1 | 2021 | 3 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2024 | 267 | 0.040 |
Why?
|
| Skin | 1 | 2022 | 185 | 0.040 |
Why?
|
| Saccharomycetales | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cosmids | 1 | 2000 | 2 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 17 | 0.040 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2021 | 110 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 57 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 173 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 90 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 38 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2000 | 81 | 0.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2020 | 19 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 711 | 0.040 |
Why?
|
| Adult | 3 | 2019 | 13458 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3077 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 64 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 139 | 0.040 |
Why?
|
| Pichia | 1 | 2019 | 10 | 0.040 |
Why?
|
| Thyroid Nodule | 1 | 2019 | 4 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2005 | 634 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 12 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 59 | 0.040 |
Why?
|
| Cell Shape | 1 | 2019 | 42 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1995 | 686 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 139 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 99 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 143 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2019 | 100 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2019 | 63 | 0.040 |
Why?
|
| Ligands | 2 | 2011 | 387 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 166 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 181 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1998 | 92 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 193 | 0.040 |
Why?
|
| Phenols | 1 | 2019 | 102 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 850 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2011 | 232 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1051 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1997 | 61 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 26 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 189 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1997 | 20 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 1997 | 25 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 34 | 0.030 |
Why?
|
| Nervous System | 1 | 1997 | 33 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 52 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 146 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 136 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 366 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 160 | 0.030 |
Why?
|
| Mitogens | 1 | 1995 | 10 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 661 | 0.030 |
Why?
|
| Deoxyribonucleotides | 1 | 1995 | 11 | 0.030 |
Why?
|
| Immunologic Tests | 1 | 2015 | 11 | 0.030 |
Why?
|
| VDJ Recombinases | 1 | 1995 | 2 | 0.030 |
Why?
|
| Marine Toxins | 1 | 1995 | 17 | 0.030 |
Why?
|
| Oxazoles | 1 | 1995 | 19 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 79 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 196 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 140 | 0.030 |
Why?
|
| Autoantigens | 1 | 2015 | 85 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 1995 | 70 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2014 | 33 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 599 | 0.030 |
Why?
|
| Dimerization | 1 | 2014 | 115 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 1995 | 235 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 456 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 454 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 84 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 602 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2014 | 106 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 884 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 928 | 0.020 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2012 | 7 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2012 | 8 | 0.020 |
Why?
|
| Plant Shoots | 1 | 2012 | 25 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 253 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 1848 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 2011 | 15 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2011 | 32 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5072 | 0.020 |
Why?
|
| Alkylation | 1 | 2011 | 11 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2011 | 64 | 0.020 |
Why?
|
| Protein Binding | 1 | 1995 | 1076 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 191 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2011 | 156 | 0.020 |
Why?
|
| Automation | 1 | 2010 | 23 | 0.020 |
Why?
|
| Soil | 1 | 2012 | 170 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 64 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 300 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 448 | 0.020 |
Why?
|
| Plant Roots | 1 | 2012 | 180 | 0.020 |
Why?
|
| Neurons | 1 | 1997 | 1246 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 311 | 0.020 |
Why?
|
| Phosphoranes | 1 | 2009 | 3 | 0.020 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2009 | 7 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 48 | 0.020 |
Why?
|
| Aging | 1 | 2014 | 764 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 134 | 0.020 |
Why?
|
| Software | 1 | 2010 | 234 | 0.020 |
Why?
|
| Drug Stability | 1 | 2009 | 127 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1987 | 37 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 350 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 160 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2007 | 165 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 1804 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1985 | 63 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 273 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 363 | 0.010 |
Why?
|
| Alleles | 1 | 1985 | 352 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 7982 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2002 | 9 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 24 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2002 | 60 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 2002 | 59 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 123 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 148 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 241 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 1997 | 1 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1997 | 48 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 1997 | 15 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 85 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 134 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 77 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1997 | 47 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 109 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1997 | 109 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 201 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1997 | 383 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1997 | 633 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 548 | 0.010 |
Why?
|
| Brain | 1 | 1997 | 1452 | 0.000 |
Why?
|
| Bursa of Fabricius | 1 | 1986 | 2 | 0.000 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1986 | 3 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1986 | 77 | 0.000 |
Why?
|
| Liver | 1 | 1986 | 503 | 0.000 |
Why?
|